Online citations, reference lists, and bibliographies.

Diabetes And Sexual Dysfunction: Current Perspectives

Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito
Published 2014 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Diabetes mellitus is one of the most common chronic diseases in nearly all countries. It has been associated with sexual dysfunction, both in males and in females. Diabetes is an established risk factor for sexual dysfunction in men, as a threefold increased risk of erectile dysfunction was documented in diabetic men, as compared with nondiabetic men. Among women, evidence regarding the association between diabetes and sexual dysfunction are less conclusive, although most studies have reported a higher prevalence of female sexual dysfunction in diabetic women as compared with nondiabetic women. Female sexual function appears to be more related to social and psychological components than to the physiological consequence of diabetes. Hyperglycemia, which is a main determinant of vascular and microvascular diabetic complications, may participate in the pathogenetic mechanisms of sexual dysfunction in diabetes. Moreover, diabetic people may present several clinical conditions, including hypertension, overweight and obesity, metabolic syndrome, cigarette smoking, and atherogenic dyslipidemia, which are themselves risk factors for sexual dysfunction, both in men and in women. The adoption of healthy lifestyles may reduce insulin resistance, endothelial dysfunction, and oxidative stress – all of which are desirable achievements in diabetic patients. Improved well-being may further contribute to reduce and prevent sexual dysfunction in both sexes.
This paper references
Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction. MUSE Study Group.
Gwyn Samuel Williams (1998)
Powered by TCPDF (www.tcpdf.org) Diabetes and sexual dysfunction
Sexual dysfunction as an obstacle to compliance with antihypertensive therapy.
Rosen Rc (1997)
10.2337/diacare.26.4.1093
Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database.
David F Penson (2003)
10.1016/S0022-5347(17)34871-1
Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.
Henry A. Feldman (1994)
10.1038/sj.ijir.3901555
Mediterranean diet improves sexual function in women with the metabolic syndrome
Katherine Esposito (2007)
10.1046/j.1464-410x.1999.00142.x
The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences.
I A Ayta (1999)
10.1016/j.jdiacomp.2010.03.003
Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management.
Vrushali S. Thorve (2011)
10.1016/S0022-5347(01)62021-4
Efficacy and Safety of Transurethral Alprostadil Therapy in Men With Erectile Dysfunction
G. Williams (1999)
10.1111/j.1743-6109.2007.00595.x
Expression of messenger ribonucleic acid encoding for phosphodiesterase isoenzymes in human female genital tissues.
Stefan Uckert (2007)
10.1038/sj.ijir.3901548
Association of body weight with sexual function in women
Katherine Esposito (2007)
10.1038/ijir.2008.36
Does cardiovascular risk reduction alleviate erectile dysfunction in men with type II diabetes mellitus?
Sameed Ahmed M. Khatana (2008)
10.1111/j.1464-410X.2006.06550.x
The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus.
A. Alhunayan (2007)
American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2013 update: a report from the American Heart Association
AS Go (2013)
10.2337/diacare.28.3.756
Sexual dysfunction in women with the metabolic syndrome.
Katherine Esposito (2005)
10.1038/clpt.2011.91
Obesity, the metabolic syndrome, and sexual dysfunction in men.
Katherine Esposito (2011)
10.1016/j.eururo.2013.08.048
A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review.
Andrea M Isidori (2014)
10.1016/j.eururo.2004.08.017
Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire.
Anton Ponholzer (2005)
10.2174/157339909788166828
Depression and Quality of Life in Patients with Diabetes: A Systematic Review from the European Depression in Diabetes (EDID) Research Consortium
Miranda T. Schram (2009)
10.1186/1472-6793-6-4
Streptozotocin-induced diabetes in the rat is associated with changes in vaginal hemodynamics, morphology and biochemical markers
Noel N Kim (2006)
10.1080/713846811
Diabetes Mellitus Induces Vaginal Tissue Fibrosis by TGF-beta; 1 Expression in the Rat Model
Kyung Hwa Park (2001)
10.7326/0003-4819-139-3-200308050-00005
Sexual Function in Men Older Than 50 Years of Age: Results from the Health Professionals Follow-up Study
Constance G Bacon (2003)
J Urol
Wayne J G Hellstrom (2014)
10.1016/S0022-5347(05)67805-6
Sexual function in men with diabetes type 2: association with glycemic control.
June Hart Romeo (2000)
10.2337/dc10-1233
Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)
Thomas Hugh Jones (2011)
10.1038/sj.ijir.3900472
Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction
R. Rosen (1999)
10.1056/NEJM199701023360101
Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group.
Harin Padma-nathan (1997)
10.1038/ijir.2010.1
Determinants of erectile dysfunction in type 2 diabetes
Francesco Giugliano (2010)
10.1007/s11892-005-0014-3
Diabetes and female sexual dysfunction: Moving beyond "benign neglect"
Ranganath Muniyappa (2005)
10.1111/j.1743-6109.2008.01209.x
Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial.
Raymond C. Rosen (2009)
10.1111/j.1463-1326.2006.00655.x
Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis.
Sayeeda Rahman (2007)
10.1016/S0022-5347(05)64638-1
Diabetes induced alteration of clitoral hemodynamics and structure in the rabbit.
Kwangsung Park (2002)
10.2337/dc13-0294
Sexual Dysfunction as a Marker of Cardiovascular Disease in Males With 50 or More Years of Type 1 Diabetes
Sara J. Turek (2013)
10.1111/j.1743-6109.2007.00649.x
Determinants of sexual function among women with type 2 diabetes in a Nigerian population.
John Kola Olarinoye (2007)
10.2337/dc13-0637
Anti-Pituitary Antibodies and Hypogonadotropic Hypogonadism in Type 2 Diabetes: In Search of a Role
Giuseppe Bellastella (2013)
10.2337/diacare.26.2.409
Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes.
Paul Enzlin (2003)
Sexual dysfunction and sexual health concerns in women with diabetes. Practical Diabetes
Dr Meeking (2013)
10.2337/diacare.28.7.1739
Clinical, socioeconomic, and lifestyle parameters associated with erectile dysfunction among diabetic men.
Ofra Kalter-Leibovici (2005)
10.2337/diacare.25.2.284
Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked.
Giorgia de Berardis (2002)
10.1111/j.1743-6109.2009.01242.x
Sexual dysfunction is frequent in premenopausal women with diabetes, obesity, and hypothyroidism, and correlates with markers of increased cardiovascular risk. A preliminary report.
Annamaria Veronelli (2009)
10.1002/PDI.1805
Sexual dysfunction and sexual health concerns in women with diabetes
Meeking (2013)
10.1093/ACREFORE/9780199975839.013.104
Diagnostic and Statistical Manual of Mental Disorders
Janet B. W. Williams (2013)
10.1016/j.eururo.2007.06.048
Daily administration of phosphodiesterase type 5 inhibitors for urological and nonurological indications.
Anthony J Bella (2007)
10.2337/diacare.26.3.777
Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study.
Irwin S. Goldstein (2003)
10.1001/jama.281.6.537
Sexual dysfunction in the United States: prevalence and predictors.
Edward O. Laumann (1999)
Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology
FA Giuliano (2004)
10.1161/CIR.0b013e31828124ad
Heart disease and stroke statistics--2013 update: a report from the American Heart Association.
Alan S. Go (2013)
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes
H Wessells (2011)
10.2337/diacare.28.1.177
Urologic complications of diabetes.
Jeanette S. Brown (2005)
QuED Study Group. Clinical and psychological predictors of incidence of self-reported erectile dysfunction in patients with type 2 diabetes
De Berardis (2007)
Sildenafil Study Group. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study
JR Berman (2003)
International Diabetes Federation. IDF Diabetes Atlas, 5th edition. Update. Brussels, Belgium: International Diabetes Federation
(2012)
10.2337/dc08-1164
Sexual Dysfunction in Women With Type 1 Diabetes
Paul Enzlin (2009)
10.1016/S0022-5347(05)67900-1
Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study.
Catherine B. Johannes (2000)
10.1080/13685530902777425
Association between severity of lower urinary tract symptoms, erectile dysfunction and metabolic syndrome
Omer Demir (2009)
10.1067/mob.2002.126641
Effects of ovariectomy and estrogen and androgen treatment on sildenafil-mediated changes in female genital blood flow and vaginal lubrication in the animal model.
Kweonsik Min (2002)
10.1016/j.eururo.2005.05.014
Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke?
Anton Ponholzer (2005)
10.1111/j.1743-6109.2006.00420.x
Erectile dysfunction severity might be associated with poor cardiovascular prognosis in diabetic men.
Raphael J Heruti (2007)
10.1016/S0085-2538(15)50896-X
Sexual dysfunction in female hemodialysis patients: a multicenter study.
Y. H. Peng (2005)
10.1016/S0022-5347(02)80386-X
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
Ivo Goldstein (1998)
10.1097/01.ju.0000125198.32936.38
The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction.
Allen D. Seftel (2004)
10.1111/j.1743-6109.2006.00221.x
The effect of diabetes mellitus treatment and good glycemic control on the erectile function in men with diabetes mellitus-induced erectile dysfunction: a pilot study.
Onder Yaman (2006)
10.1001/jama.281.5.421
Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.
Marc S Rendell (1999)
10.1038/ijir.2010.6
Determinants of female sexual dysfunction in type 2 diabetes
Katherine Esposito (2010)
10.2337/diacare.27.5.1047
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.
Sarah H Wild (2004)
10.1111/j.1743-6109.2009.01219.x
Association of glycemic control with risk of erectile dysfunction in men with type 2 diabetes.
Chih-Chen Lu (2009)
10.1056/NEJM199805143382001
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
Irwin Goldstein* (1998)
10.1016/j.mayocp.2012.06.015
The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease.
Ajay X Nehra (2012)
Erectile dysfunction in diabetes mellitus.
Maria Moța (2003)
10.1111/j.1743-6109.2009.01458.x
Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial.
Rena R Wing (2010)
10.1111/ceo.12099
Relationship between diabetic retinopathy, diabetic macular oedema and erectile dysfunction in type 2 diabetics.
Sky K. H. Chew (2013)
10.2164/jandrol.108.006486
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations.
Christine Y. Wang (2009)
J Hypertens
(2006)
10.1161/CIRCULATIONAHA.106.658948
Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus: The Framingham Heart Study
Caroline S Fox (2007)
10.1111/j.1743-6109.2009.01284.x
Hyperlipidemia and sexual function in premenopausal women.
Katherine Esposito (2009)
10.1046/j.0742-3071.2001.00557.x
Prevalence of and risk factors for erectile dysfunction in Hong Kong diabetic patients.
Sai Cheong Siu (2001)
Metabolic Syndrome and Obesity: Targets and Therapy downloaded from https://www.dovepress.com/ by 54.191.40.80 on 31-Mar-2017 For personal use only
10.7326/0003-4819-92-2-255
[Diabetic autonomic neuropathy].
Amalia Alcón (1989)
10.1111/j.1365-2605.2008.00932.x
Clinical and metabolic evaluation of subjects with erectile dysfunction: a review with a proposal flowchart.
Carlo Foresta (2009)
10.2337/diacare.25.12.2159
Effects of tadalafil on erectile dysfunction in men with diabetes.
Iñigo Sáenz de Tejada (2002)
10.1111/j.1743-6109.2009.01617.x
Summary of the recommendations on sexual dysfunctions in women.
Rosemary Basson (2010)
10.1016/j.ecl.2007.03.007
ED2: erectile dysfunction = endothelial dysfunction.
André T. Guay (2007)
10.1016/j.diabres.2013.08.003
International Diabetes Federation.
Ronan L'Heveder (2013)
10.1016/j.ecl.2007.02.001
Treatment options for erectile dysfunction.
William O. Brant (2007)
10.1007/BF00250156
Sexual responsiveness in diabetic women
G M Tyrer (2004)
10.1016/j.ucl.2011.04.006
Lifestyle/dietary recommendations for erectile dysfunction and female sexual dysfunction.
Katherine Esposito (2011)
10.2337/diacare.28.5.1201
High proportions of erectile dysfunction in men with the metabolic syndrome.
Katherine Esposito (2005)
10.2337/diacare.29.02.06.dc05-1067
Sexual function and endocrine profile in fertile women with type 1 diabetes.
Andrea Salonia (2006)
10.1111/jsm.12065
Female sexual dysfunction and diabetes: a systematic review and meta-analysis.
Antonio E. Pontiroli (2013)
Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat
MG Ferrini (2007)
Powered by TCPDF (www.tcpdf.org)
10.1001/jama.270.1.83
NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence.
(1993)
10.1016/j.juro.2010.12.098
Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes.
Hunter Wessells (2011)
10.1056/NEJM199309303291401
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group.
Paul Saenger (1993)
10.1111/j.1743-6109.2007.00714.x
Male erectile dysfunction and cardiovascular disease: is there an intimate nexus?
Kew-Kim Chew (2008)
10.1111/j.1743-6109.2012.02649.x
Cardiometabolic risk and female sexual health: the Princeton III summary.
Martin Miner (2012)
Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 submit your manuscript | www.dovepress.com Dovepress Dovepress 103 Diabetes and sexual dysfunction
International Diabetes Federation. IDF Diabetes Atlas Update. Brussels, Belgium: International Diabetes Federation
(2012)
10.2337/dc09-0910
Sexual Dysfunction in Women With Type 1 Diabetes: Long-Term Findings From the DCCT/EDIC Study Cohort
Ketan K Dhatariya (2010)
10.1111/j.1743-6109.2011.02517.x
Prevalence of sexual dysfunction among postmenopausal women with and without metabolic syndrome.
Valentina Martelli (2012)
International Diabetes Federation. Diabetes Atlas
(2011)
10.1093/ajhp/61.2.160
Diabetic neuropathy: an intensive review.
Jeremiah J. Duby (2004)
10.1111/j.1742-1241.2006.01101.x
The evolving role of testosterone in the treatment of erectile dysfunction.
Ridwan Shabsigh (2006)
10.1111/jsm.12034
Sexual health issues in women with cancer.
Michael L. Krychman (2013)
10.1097/AOG.0b013e3181898cdb
Sexual Problems and Distress in United States Women: Prevalence and Correlates
Jan L. Shifren (2008)
10.1016/j.coph.2011.08.004
PDE5 inhibitors: targeting erectile dysfunction in diabetics.
Sharron H. Francis (2011)
10.1016/j.juro.2006.08.102
Clinical and psychological predictors of incidence of self-reported erectile dysfunction in patients with type 2 diabetes.
Giorgia de Berardis (2007)
10.2337/dc08-9026
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
Jay S Skyler (2009)
10.1016/S0090-4295(02)02102-7
Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction.
Alfredo Nicolosi (2003)
10.2337/diacare.21.11.1973
Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici.
Domenico Fedele (1998)
The causes and prevalence of hypoactive sexual desire disorder: part I.
Melissa Feldhaus-Dahir (2009)
10.1016/S0094-0143(05)70139-7
Neurologic erectile dysfunction.
Ajay X Nehra (2001)
10.1016/j.urology.2004.08.059
Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both.
François A Giuliano (2004)
10.1007/978-1-4613-1105-8_1
Pathophysiology of Erectile Dysfunction.
Melman (1999)
10.1159/000049805
Cigarette Smoking: A Risk Factor for Erectile Dysfunction in Diabetics
Angela Bortolotti (2001)
10.1016/j.jacc.2003.11.002
Erectile dysfunction: the earliest sign of generalized vascular disease?
Melvin D. Cheitlin (2004)
10.1038/sj.ijir.3901500
Endothelial microparticles correlate with erectile dysfunction in diabetic men
Katherine Esposito (2007)
10.1002/clc.4960260106
Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israeli men.
Arie Roth (2003)
10.3275/8969
The SUBITO-DE study: Sexual dysfunction in newly diagnosed Type 2 diabetes male patients
Giuseppe Corona (2013)
10.1111/j.1743-6109.2010.01714.x
Adherence to Mediterranean diet and sexual function in women with type 2 diabetes.
Francesco Giugliano (2010)
10.1111/j.1743-6109.2010.01990.x
Sexual function in obese women with and without binge eating disorder.
Giovanni Castellini (2010)
10.1161/CIRCULATIONAHA.108.846519
Trends in Cardiovascular Disease Risk Factors in Individuals With and Without Diabetes Mellitus in the Framingham Heart Study
Sarah Rosner Preis (2009)
10.1016/S0022-5347(05)67828-7
Report of the international consensus development conference on female sexual dysfunction: definitions and classifications.
R Basson (2000)
Effect of Intensive Lifestyle Intervention on Sexual Dysfunction inWomen With Type 2 Diabetes Results from an ancillary Look AHEAD study
Rena R Wing (2013)
10.1111/j.1743-6109.2010.01778.x
Definitions/epidemiology/risk factors for sexual dysfunction.
Ronald William Lewis (2010)
10.1016/j.eururo.2006.02.052
Evaluation of the Efficacy and Safety of Once-a-Day Dosing of Tadalafil 5 mg and 10 mg in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Hartmut Porst (2006)
10.1097/01.hjh.0000251898.40002.5b
Female sexual dysfunction in essential hypertension: a common problem being uncovered
Michael Doumas (2006)
10.1038/sj.ijir.3900648
Effects of diabetes on neurotransmission in rat vaginal smooth muscle
Annamaria Giraldi (2001)
10.2337/diacare.25.8.1458
Association of type and duration of diabetes with erectile dysfunction in a large cohort of men.
Constance G Bacon (2002)
10.1002/14651858.CD002187.pub3
Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus.
MosheY. Vardi (2007)
Sexual dysfunction as an obstacle to compliance with antihypertensive therapy.
Raymond C. Rosen (1997)
10.1097/01.ju.0000090966.74607.34
Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study.
Jennifer R. Berman (2003)
10.1002/(SICI)1096-9136(199810)15:10<809::AID-DIA689>3.0.CO;2-Z
Diabetes mellitus and female sexuality: a review of 25 years' research.
Paul Enzlin (1998)
Diabetes and sexual dysfunction
Lester J Goetz (1996)
Metabolic Syndrome and Obesity: Targets and Therapy downloaded from https://www.dovepress.com/ by 54.191.40.80 on 03-Apr-2017 For personal use only
10.1210/jc.2004-0804
Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes.
Sandeep Dhindsa (2004)
10.1056/nejm199807023390121
ORAL SILDENAFIL IN THE TREATMENT OF ERECTILE DYSFUNCTION
Arin (2000)
10.2337/dc08-0081
Sexual Dysfunction in Jordanian Diabetic Women
Ruba M. Abu Ali (2008)
10.1111/j.1743-6109.2009.01396.x
Frequency and correlates of sexual dysfunction in women with diabetes mellitus.
Anthonia Okeoghene Ogbera (2009)
10.1016/S0140-6736(07)60280-3
Sexual dysfunction in men and women with endocrine disorders
Shalender Bhasin (2007)
10.1111/j.1743-6109.2007.00473.x
Sexual function in female patients with unstable angina or non-ST-elevation myocardial infarction.
Moustafa M. K. Eyada (2007)
10.1038/35007508
Obesity as a medical problem
Peter G. Kopelman (2000)
10.3810/pgm.2012.11.2615
Chronic Hyperglycemia and Glucose Toxicity: Pathology and Clinical Sequelae
Carlos Campos (2012)
10.1111/j.1743-6109.2008.01030.x
Effects of intensive lifestyle changes on erectile dysfunction in men.
Katherine Esposito (2009)
10.1056/NEJMoa067423
A study of sexuality and health among older adults in the United States.
Stacy Tessler Lindau (2007)
10.1136/bmj.321.7258.405
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
Irene M. Stratton (2000)
Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412
A Roth (2003)
10.1210/jc.2010-2724
Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity.
Paresh Dandona (2011)
10.2337/dc06-1426
Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes
Dheeraj Kapoor (2007)
10.2174/138161209789206953
Phosphodiesterase-5 inhibitors: future perspectives.
Giannitsas Konstantinos (2009)
10.1530/EJE-08-0601
Investigation, treatment and monitoring of late-onset hypogonadism in males
Chun-mei Wang (2008)
10.1111/j.1743-6109.2009.01354.x
Erectile dysfunction and mortality.
Andre Araujo (2009)
10.1080/1468199031000099415
Sexual function in diabetic women: A psychological perspective
Claire Rockliffe-Fidler (2003)
10.1111/j.1743-6109.2009.01599.x
Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms?
Meredith L Chivers (2010)
10.1016/S0015-0282(02)03001-7
Hormones, mood, sexuality, and the menopausal transition.
Lorraine Dennerstein (2002)
10.1016/j.jacc.2011.06.024
Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies.
Jia-Yi Dong (2011)
10.14310/HORM.2002.1309
Sexual dysfunction in diabetic women
Alexandra Bargiota (2011)



This paper is referenced by
10.1007/978-3-030-36694-0
Diabetes Complications, Comorbidities and Related Disorders
Enzo Bonora (2020)
10.1007/s40619-017-0276-4
Disturbi della sessualità nel paziente diabetico
G. De Luca (2017)
10.1111/jdi.13089
What is the best biological parameter to predict erectile dysfunction in men aged >55 years with type 2 diabetes?
Sitraka A Raharinavalona (2019)
Sexual Dysfunction and Sexual Quality of Life in Women with Diabetes: The Study Based on a Diabetic Center
Selda CelikZehra (2015)
10.1016/j.cbi.2019.108869
Protective effects of Salidroside on spermatogenesis in streptozotocin induced type-1 diabetic male mice by inhibiting oxidative stress mediated blood-testis barrier damage.
Ya-Ping Jiang (2019)
10.1007/s11930-019-00224-9
From Table to Bedroom: Nutritional Status, Dietary Interventions, and Women’s Sexual Function
Sean M. McNabney (2019)
10.1038/ijir.2017.3
The relationship between acquired premature ejaculation and metabolic syndrome: a prospective, comparative study
Duygu Bolat (2017)
10.1016/j.apnr.2015.04.007
Recognising female sexual dysfunction as an essential aspect of effective diabetes care.
A. L. Phillips (2015)
10.5897/AJPP2015.4450
Efficacy of Tribulus terrestris extract and metformin on fertility indices and oxidative stress of testicular tissue in streptozotocin-induced diabetic male rats
Hend M Tag (2015)
10.1016/J.JSXM.2016.03.060
PS-05-005 Bringing the body of the iceberg to the surface: the Female Sexual Dysfunction Index-6 (FSDI-6) in the screening of female sexual dysfunction
Elisa Maseroli (2016)
10.1007/s11255-016-1221-3
Effects of adipose-derived stem cells plus insulin on erectile function in streptozotocin-induced diabetic rats
Feng Zhou (2016)
Effect of PLISSIT Model Sexual Counseling on Sexual Function among Women with Diabetes
Dr. Nahed Fikry Hassan Khedr (2018)
10.1016/j.soard.2016.09.022
Sexual functioning of men and women with severe obesity before bariatric surgery.
Kristine J. Steffen (2017)
10.1042/CS20180192
Decreased expression of pigment epithelium-derived factor within the penile tissues contributes to erectile dysfunction in diabetic rats.
Hongjie Qiao (2018)
10.21522/TIJPH.2013.06.02.ART009
Erectile Dysfunction among Diabetic Patients at Parirenyatwa Group of Hospitals in Zimbabwe
Pasipanodya Ian Machingura (2018)
10.1016/j.apjtm.2017.03.001
In vitro and in vivo investigation of natural compounds from seed extract of Mucuna pruriens lacking l-DOPA for the treatment of erectile dysfunction.
Natthachai Duangnin (2017)
10.1111/and.12924
Essential role of brain‐derived neurotrophic factor (bdnf) in diabetic erectile dysfunction
Liangliang Hu (2018)
10.1016/j.ihj.2018.05.006
Erectile dysfunction severity as a predictor of left main and/or three-vessel disease in acute coronary syndrome patients
Mohammad Mostafa Al-Daydamony (2018)
10.1080/0092623X.2018.1494647
Validity and Reliability of the Golombok-Rust Inventory of Sexual Satisfaction (GRISS) in Patients With Type 2 Diabetes
Nafiu Amidu (2019)
10.1111/and.13364
Study of the prevalence and patterns of phosphodiesterase type 5 inhibitor use among sexually active Egyptian males: A National Cross-sectional Survey.
Attia Abd-Allah Attia (2019)
10.1038/ijir.2016.38
Erectile dysfunction in young men with type 1 diabetes
Maria Ida Maiorino (2017)
10.1111/jsm.12960
A Toll-Like Receptor 1/2 Agonist Augments Contractility in Rat Corpus Cavernosum.
Inger S Stallmann-Jorgensen (2015)
10.4103/1995-7645.242311
Acute and chronic toxicity studies of hydromethanol leaf extract of Helianthus annuus Linn. in rats
Samuel O. Onoja (2018)
10.1007/s13300-018-0475-4
Diabetic Gastroparesis
Sanjay Kalra (2018)
10.4103/UROS.UROS_1_19
Knowledge, attitude, confidence, and barriers in the practice of erectile dysfunction screening among primary health-care providers in Taiping Perak, Malaysia
Chai Li Tay (2019)
10.1016/j.jsxm.2019.01.010
Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part III.
Sharon J. Parish (2019)
10.1016/j.jsxm.2020.02.010
Mechanosensitive Vaginal Epithelial Adenosine Triphosphate Release and Pannexin 1 Channels in Healthy, in Type 1 Diabetic, and in Surgically Castrated Female Mice.
Jessica Harroche (2020)
10.1093/tbm/ibz188
SMART2D-development and contextualization of community strategies to support self-management in prevention and control of type 2 diabetes in Uganda, South Africa, and Sweden.
Pilvikki Absetz (2020)
10.3109/13685538.2015.1083972
Hormonal determinants of erectile dysfunction and lower urinary tract symptoms in middle-aged and elderly men with prediabetes
Michał Rabijewski (2015)
10.4103/jehp.jehp_33_15
Sexual function and quality of life in diabetic women referring to health care centers in Mashhad
Mahin Tafazoli (2017)
10.1186/s13104-018-3881-9
Profiling the mental health of diabetic patients: a cross-sectional survey of Zimbabwean patients
Alima M Nyoni (2018)
10.4236/ojemd.2018.83009
A Study of the Correlation between Angiotensin (1-7) and the Histopathological Changes in the Penises of Experimentally Diabetic Rats
Abdelaal M. El Kamshoushi (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar